Technical Analysis for ALRN - Aileron Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 2.17 -3.56% -0.08
ALRN closed down 3.56 percent on Friday, November 16, 2018, on 19 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical ALRN trend table...

Date Alert Name Type % Chg
Nov 16 Fell Below 20 DMA Bearish 0.00%
Nov 16 Narrow Range Bar Range Contraction 0.00%
Nov 16 NR7 Range Contraction 0.00%
Nov 16 Inside Day Range Contraction 0.00%
Nov 15 Crossed Above 20 DMA Bullish -3.56%
Nov 15 Up 3 Days in a Row Strength -3.56%
Nov 14 20 DMA Resistance Bearish -1.81%
Nov 14 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.81%
Nov 14 MACD Bullish Signal Line Cross Bullish -1.81%
Nov 13 20 DMA Resistance Bearish -1.36%

Older signals for ALRN ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Aileron Therapeutics, Inc. is a United States-based clinical-stage biopharmaceutical company. The Company is focused on developing and commercializing a class of therapeutics called stapled peptides. It is also developing a pipeline of stapled peptide drugs across a range of therapeutic areas, including cancer, endocrine and metabolic diseases and inflammation. The Company is advancing its lead oncology program to deliver efficacy and safety in a spectrum of solid and hematological malignancies. Its lead product candidate, ALRN-6924, targets the tumor suppressor protein p53 for the treatment of a range of cancers. The Company is conducting an ongoing Phase I clinical trial of ALRN-6924 in adult patients with solid tumors or lymphomas expressing non-mutated or wild-type p53 that are refractory to or intolerant of standard therapy. ALRN-6924 may reactivate p53-mediated cell death by targeting both of the natural p53 suppressor proteins, Mouse double minute 2 homolog (MDM2) and MDMX.
Is ALRN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.5
52 Week Low 1.75
Average Volume 67,794
200-Day Moving Average 4.8897
50-Day Moving Average 2.553
20-Day Moving Average 2.198
10-Day Moving Average 2.102
Average True Range 0.3175
ADX 18.63
+DI 14.1723
-DI 17.5174
Chandelier Exit (Long, 3 ATRs ) 1.7475
Chandelier Exit (Short, 3 ATRs ) 2.7025
Upper Bollinger Band 2.4924
Lower Bollinger Band 1.9036
Percent B (%b) 0.45
BandWidth 26.787989
MACD Line -0.1176
MACD Signal Line -0.1467
MACD Histogram 0.0291
Fundamentals Value
Market Cap 31.93 Million
Num Shares 14.7 Million
EPS -41.73
Price-to-Earnings (P/E) Ratio -0.05
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.31
Resistance 3 (R3) 2.30 2.25 2.28
Resistance 2 (R2) 2.25 2.22 2.25 2.27
Resistance 1 (R1) 2.21 2.19 2.19 2.22 2.27
Pivot Point 2.16 2.16 2.15 2.16 2.16
Support 1 (S1) 2.12 2.13 2.10 2.13 2.07
Support 2 (S2) 2.07 2.10 2.07 2.07
Support 3 (S3) 2.03 2.07 2.06
Support 4 (S4) 2.04